Albert Mitrani

Insider Reports History

Reporting-owner location: Miami Beach, FL
Latest reporting-owner signature: /s/ Albert Mitrani
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Albert Mitrani

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Organicell Regenerative Medicine, Inc.

Security class: Common Stock
Shares / value: 166,790,190
Estimated value: $219,329,100
Report date: 29 Oct 2021
Price: $1.32
Ownership: Direct

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Organicell Regenerative Medicine, Inc.

Security class: Common Stock
Shares / value: 116,707,890
Estimated value: $153,470,875
Report date: 29 Oct 2021
Price: $1.32
Ownership: Additional shares held by spouse

Insider Reports Filed by Albert Mitrani

4 ZEOX

Organicell Regenerative Medicine, Inc.

Report period: 29 Oct 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 02 Nov 2021, 21:52
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 ZEOX

Organicell Regenerative Medicine, Inc.

Report period: 17 Jun 2021
Transactions: 1
Transaction value: -$7,000
Accepted by SEC: 21 Jun 2021, 21:00
Role: President, Director, 10%+ Owner
Next action: Open filing details

4 ZEOX

Organicell Regenerative Medicine, Inc.

Report period: 14 Jun 2021
Transactions: 5
Transaction value: -$29,069
Accepted by SEC: 16 Jun 2021, 21:44
Role: President, Director, 10%+ Owner
Next action: Open filing details

4 ZEOX

Organicell Regenerative Medicine, Inc.

Report period: 09 Jun 2021
Transactions: 5
Transaction value: -$41,500
Accepted by SEC: 11 Jun 2021, 21:45
Role: President, Director, 10%+ Owner
Next action: Open filing details

4 ZEOX

Organicell Regenerative Medicine, Inc.

Report period: 04 Jun 2021
Transactions: 6
Transaction value: -$39,900
Accepted by SEC: 08 Jun 2021, 21:45
Role: President, Director, 10%+ Owner
Next action: Open filing details

4 ZEOX

Organicell Regenerative Medicine, Inc.

Report period: 01 Jun 2021
Transactions: 3
Transaction value: -$24,700
Accepted by SEC: 03 Jun 2021, 21:45
Role: President, Director, 10%+ Owner
Next action: Open filing details

4 ZEOX

Organicell Regenerative Medicine, Inc.

Report period: 26 May 2021
Transactions: 5
Transaction value: -$34,967
Accepted by SEC: 28 May 2021, 21:42
Role: President, Director, 10%+ Owner
Next action: Open filing details

4 ZEOX

Organicell Regenerative Medicine, Inc.

Report period: 21 May 2021
Transactions: 4
Transaction value: -$37,700
Accepted by SEC: 25 May 2021, 21:44
Role: President, Director, 10%+ Owner
Next action: Open filing details

4 ZEOX

Organicell Regenerative Medicine, Inc.

Report period: 13 May 2021
Transactions: 5
Transaction value: -$52,807
Accepted by SEC: 20 May 2021, 21:45
Role: President, Director, 10%+ Owner
Next action: Open filing details

4 ZEOX

Organicell Regenerative Medicine, Inc.

Report period: 13 May 2021
Transactions: 4
Transaction value: -$41,100
Accepted by SEC: 17 May 2021, 21:45
Role: President, Director, 10%+ Owner
Next action: Open filing details

4 ZEOX

Organicell Regenerative Medicine, Inc.

Report period: 10 May 2021
Transactions: 4
Transaction value: -$50,775
Accepted by SEC: 12 May 2021, 21:45
Role: President, Director, 10%+ Owner
Next action: Open filing details

4 ZEOX

Organicell Regenerative Medicine, Inc.

Report period: 05 May 2021
Transactions: 6
Transaction value: -$55,588
Accepted by SEC: 07 May 2021, 21:45
Role: President, Director, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .